We are live on
!
Find out more
PM
Penbrook Management Portfolio holdings
AUM
$157M
1-Year Est. Return
46.57%
This Fund
S&P 500
This Quarter
Est. Return
+4.84%
1 Year Est. Return
+46.57%
3 Year Est. Return
+105.97%
5 Year Est. Return
+154.19%
10 Year Est. Return
–
AUM
$113M
AUM Growth
+$7.49M
(+7.1%)
Cap. Flow
+$5.21M
Cap. Flow
% of AUM
4.6%
Top 10 Holdings %
Top 10 Hldgs %
25.33%
Holding
120
New
14
Increased
34
Reduced
28
Closed
2
Avg Time Held
1.7
quarters
Top 10 Avg Time Held
1.4
quarters
Top 20 Avg Time Held
1.6
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
EPIQ
EPIQ SYSTEMS INC
EPIQ
|
+$1.21M |
| 2 |
Kestrel Group
KG
|
+$945K |
| 3 |
RLOC
REACHLOCAL INC COM STK (DE)
RLOC
|
+$879K |
| 4 |
TECU
TECUMSEH PRODUCTS COMPANY COMMON STOCK
TECU
|
+$762K |
| 5 |
WMAR
West Marine Inc
WMAR
|
+$477K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TECUA
TECUMSEH PRODUCTS CO CL-A
TECUA
|
+$926K |
| 2 |
Harvard Bioscience
HBIO
|
+$500K |
| 3 |
Radiant Logistics
RLGT
|
+$294K |
| 4 |
TURN
180 Degree Capital
TURN
|
+$252K |
| 5 |
SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
|
+$190K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.61% |
| 2 | Healthcare | 14.96% |
| 3 | Miscellaneous | 14.69% |
| 4 | Energy | 13.36% |
| 5 | Financials | 10.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Novo Nordisk
NVO
$171B
| $5.87M | 5.18% |
254,000
| – | – |
2013 Q4
2 quarters
|
|
2
Microsoft
MSFT
$3.97T
| $3.39M | 3% |
81,344
-400
| -0.5% | -$16.2K |
2013 Q4
2 quarters
|
|
|
AFFX
3
DELISTED
Affymetrix Inc
AFFX
| $2.73M | 2.41% |
306,700
+2,200
| +0.7% | +$17.5K |
2013 Q4
2 quarters
|
|
4
Fidelity National Financial
FNF
$10.4B
| $2.65M | 2.34% |
141,959
| – | – |
2013 Q4
2 quarters
|
|
5
Calumet Specialty Products
CLMT
$4.96B
| $2.63M | 2.32% |
82,781
-800
| -1% | -$23.8K |
2013 Q4
2 quarters
|
|
6
Baytex Energy
BTE
$3.36B
| $2.61M | 2.31% |
56,598
+325
| +0.6% | +$13.8K |
2013 Q4
2 quarters
|
|
7
Alphabet (Google) Class C
GOOG
$4.25T
| $2.49M | 2.2% |
86,216
+616
| +0.7% | +$16.7K |
2013 Q4
2 quarters
|
|
8
Immersion
IMMR
$247M
| $2.25M | 1.99% |
176,736
+3,900
| +2% | +$42.3K |
2013 Q4
2 quarters
|
|
|
FEIC
9
DELISTED
FEI COMPANY
FEIC
| $2.06M | 1.82% |
22,655
+275
| +1% | +$24.2K |
2013 Q4
2 quarters
|
|
10
Core Laboratories
CLB
$463M
| $2M | 1.76% |
11,958
-150
| -1% | -$26.7K |
2013 Q4
2 quarters
|
|
|
EPAY
11
DELISTED
Bottomline Technologies Inc
EPAY
| $2M | 1.76% |
66,710
| – | – |
2013 Q4
2 quarters
|
|
|
12
Harvard Bioscience
HBIO
$37.5M
| $1.98M | 1.75% |
43,475
-11,896
| -21% | -$500K |
2013 Q4
2 quarters
|
|
13
DELISTED
Legacy Reserves Inc. Common Stock
LGCY
| $1.94M | 1.72% |
62,240
+550
| +0.9% | +$15.2K |
2013 Q4
2 quarters
|
|
|
ARRS
14
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $1.91M | 1.68% |
58,567
-441
| -0.7% | -$13K |
2013 Q4
2 quarters
|
|
|
PRCP
15
DELISTED
Perceptron Inc
PRCP
| $1.88M | 1.66% |
147,458
+400
| +0.3% | +$4.73K |
2013 Q4
2 quarters
|
|
|
NUAN
16
DELISTED
Nuance Communications, Inc.
NUAN
| $1.85M | 1.63% |
113,652
+3,032
| +3% | +$43.9K |
2013 Q4
2 quarters
|
|
|
AFOP
17
DELISTED
Alliance Fiber Optic Prod Inc
AFOP
| $1.84M | 1.63% |
101,800
+2,075
| +2% | +$39.2K |
2014 Q1
1 quarter
|
|
|
XCRA
18
DELISTED
Xcerra Corporation
XCRA
| $1.83M | 1.62% |
201,051
+700
| +0.3% | +$6.44K |
2013 Q4
2 quarters
|
|
19
DELISTED
iRobot
IRBT
| $1.81M | 1.6% |
44,125
+1,425
| +3% | +$51.5K |
2013 Q4
2 quarters
|
|
20
Targa Resources
TRGP
$61.5B
| $1.72M | 1.52% |
12,300
| – | – |
2013 Q4
2 quarters
|
|
21
Encore Capital Group
ECPG
$2.12B
| $1.62M | 1.43% |
35,684
-100
| -0.3% | -$4.42K |
2013 Q4
2 quarters
|
|
22
Synopsys
SNPS
$97.7B
| $1.62M | 1.43% |
41,650
+200
| +0.5% | +$7.63K |
2013 Q4
2 quarters
|
|
23
Data I/O
DAIO
$30.3M
| $1.61M | 1.42% |
533,550
+600
| +0.1% | +$1.61K |
2013 Q4
2 quarters
|
|
|
AGN
24
DELISTED
Allergan Inc
AGN
| $1.57M | 1.39% |
9,300
-700
| -7% | -$109K |
2013 Q4
2 quarters
|
|
|
ESIO
25
DELISTED
Electro Scientific Industries
ESIO
| $1.55M | 1.37% |
227,560
+8,800
| +4% | +$70.2K |
2013 Q4
2 quarters
|
|
Similar funds
AFW
QGA
AWA
BGAI
AIG
MFG
BCM
MCM
Penbrook Management's Q2 2014 Portfolio in Review
As of Q2 2014, Penbrook Management held 120 positions worth $113M, up 7.1% from $106M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Penbrook Management deployed $5.21M of net new capital in Q2 2014, opening 14 new positions and adding to 34 existing holdings. Its largest new stake was EPIQ SYSTEMS INC: 92,800 shares worth $1.3M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Miscellaneous.
On the sell side, the largest reduction was Harvard Bioscience, an estimated $500K trimmed.
- Penbrook Management's largest Q2 2014 buy was EPIQ SYSTEMS INC: 92,800 shares worth $1.3M.
- Penbrook Management added most to Lightpath Technologies in Q2 2014, an estimated $210K increase.
- Penbrook Management's biggest Q2 2014 reduction was Harvard Bioscience, cutting an estimated $500K.
- Penbrook Management fully exited TECUMSEH PRODUCTS CO CL-A in Q2 2014, selling an estimated $926K.
- Penbrook Management's ten largest holdings make up 25% of its $113M portfolio in Q2 2014.
- Penbrook Management opened 14 new positions and closed 2 in Q2 2014.
- Penbrook Management's portfolio value rose 7.1% quarter-over-quarter to $113M.
Based on Penbrook Management's 13F filing for Q2 2014, filed 4 Aug 2014.